Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pizga Kumwenda has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analysis of rpoB mutations associated with rifampicin resistance in Mycobacterium tuberculosis isolates in Malawi

    by Stewart Soko, Pizga Kumwenda

    Rifampicin-resistant tuberculosis (RR-TB) remains a major challenge for TB control in Malawi, particularly in densely populated districts such as Blantyre.


  • Open Access

    Characterization of urinary tract infections among females at a tertiary hospital in Malawi: a retrospective study

    by Pizga Kumwenda, Precious Semu

    Urinary tract infections (UTIs) are among the most common infections in females, with many experiencing at least one episode in their lifetime. About 150 million cases of UTIs occur each year. Lately, the prognosis of UTIs has been poor, largely due to a rise in antimicrobial resistance among common uropathogens. The present study was conducted to describe UTIs in female clients at Zomba Central Hospital in Malawi. This was a retrospective cross-sectional study where 340 records of women suffering from UTIs were evaluated. Records were analysed for demographic characteristics, the causative agent of UTIs and their antimicrobial susceptibility profile. Data were cleaned and analysed in Excel 2016. The overall prevalence of UTIs was 48.53%, with age group 15–45 having a higher frequency (53.33%) than other age groups. The most frequently isolated bacteria were Escherichia coli (27.2%), Staphylococcus species (26.5%), Enterobacter species (19.2%), Citrobacter freundii (11.9%), Proteus species (6.0%), Enterococcus species, and Serratia marcescens (4.6%). Comparatively, meropenem and amikacin were effective against most pathogens showing average sensitivity rates of 51% and 56% respectively. Nevertheless, high levels of resistance to ampicillin (87%), ceftriaxone (77%) ciprofloxacin (70%), gentamicin (77%), and cefoxitin (64%) were observed. UTIs remain a significant health concern among females at Zomba Central Hospital, particularly in the reproductive age group. The high prevalence of multidrug-resistant uropathogens, especially against commonly used antibiotics like ampicillin and ceftriaxone, underscores the urgent need for regular antimicrobial resistance surveillance and evidence-based antibiotic stewardship to guide effective treatment strategies. Not applicable.


  • Open Access

    Knowledge, Attitudes, and Practices on COVID-19 Vaccination among General Adult Population in Malawi: A Countrywide Cross-Sectional Survey

    by Master R. O. Chisale, Dzinkambani Kambalame, Saul Eric Mwale, Balwani Chingatichifwe Mbakaya, Regina Mankhamba, Pizga Kumwenda, Ben Chilima, Collins Mitambo, Mavuto Chiwaula, Billy Nyambalo, et al.

    Vaccination is one of the essential measures in reducing transmission, morbidity, and mortality rates of a disease. However, the COVID-19 vaccination is facing hesitancy across the globe, Malawi included. A population-based cross-sectional study was conducted in Malawi to document knowledge, attitudes, and practices on COVID-19 vaccination. The study targeted the general adult population and employed a multi-stage sampling technique. The Census Enumeration Areas within the 16 selected districts served as a primary sampling unit. Among the total 3068 participants, 1947 (63.6%) were female. About 1039 (34.1%) participants had primary education, while only 169 (5.5%) had college education. A total of 2936 (95.7%) participants knew about the COVID-19 vaccine, and 2063 (68.4%) felt that the COVID-19 vaccine was effective. A total of 1180 (38.7%) got vaccinated. Knowledge of the COVID-19 vaccination was significantly associated with participants’ education levels, location, occupation, marital status, household family income, and whether they were suffering from chronic illness or not. Overall, the level of knowledge and attitudes about the COVID-19 vaccination was good. This study has also established that different population groups have statistically different levels of knowledge and attitudes regarding COVID-19 vaccination. This study has also indicated a significant relationship between the rate of vaccination and several factors. Therefore, this calls for stakeholders to continue awareness and group-targeted tailored campaigns so as to increase COVID-19 vaccination.


  • Open Access

    Negative blood culture results are influenced by antibiotic treatment: A retrospective study at Malamulo Adventist Hospital, Thyolo, Malawi

    by Chikondi Kamwendo, Pizga Kumwenda

    Background Blood culture is a laboratory test designed to detect the presence of bacteria or fungi in the blood of patients suspected of blood stream infection. While speedy initiation of antibiotic treatment is a critical determinant of patient survival, it is recommended that sample for blood culture should be collected before initiation of antibiotic therapy. The present study assessed the effects of antibiotic treatment on blood culture negativity. Methods A retrospective observational study was conducted to review blood culture results from June 2021 to December 2022. Blood culture results from patients aged 0 to 60 years were examined. Blood culture results whose samples were obtained prior to antibiotic treatment were analysed in comparison to those obtained during antibiotic treatment. Altogether a total of 165 results from various wards were analysed. Results Out of 94 blood cultures tested prior to antibiotic treatment, 54 were negative reflecting a negativity rate of 57%. Furthermore, from 71 blood cultures analysed after initiating antibiotic treatment, 56 were negative, representing a negativity rate of 79% (56/71). Thus, blood samples collected post antibiotic treatment exhibited a higher blood culture negativity rate in comparison to blood samples collected before the onset of antibiotic treatment. Conclusions This study revealed that collecting blood culture samples after the start of antibiotic treatment promotes blood culture negativity. While prompt initiation of antibiotic therapy is vital for patient recovery and survival in sepsis or bacteraemia, we encourage the practice of collecting blood culture samples prior to the commencement of treatment.

  • Open Access

    Prevalence of Immunoglobulin (G (IgG) and M (IgM)) Against SARS-COV-2 and risk factors for positivity among Students at tertiary education institution, Malawi

    by Saul Eric Mwale, Master Chisale, McLenelious Chimenya, Twalibu N.G. Tandwe, Yankho Chapeta, Michael Mzirekelenge Nkosi, Billy Wilson Nyambalo, Jomo Ngonga, Paul Munyenyembe, Winfred Kayange, et al.

    Objective The aim of our study was to determine the extent of exposure of the student population to SARS-CoV-2 and its associated factors. 166 students were enrolled in our study representing a 100% response rate. Results The SARS-CoV-2 antibody seroprevalence in the sampled student population was 78%. Gender of the respondents was a significant modulator of SARS-CoV-2 seropositivity (p < 0.05). Adherence to the institution’s SARS-CoV-2 containment measures by students was very low (6.6%) which numerically amplified the seropositivity among students. There were proportional differences in the use of a particular Covid-19 mitigation strategy by the students such as face masks (60.2%), hand sanitizers (38.6%), Social distancing (25.9%), handwashing with soap (7.8%) and self-isolation (5.4%) (Cochran Q = 155.39, p < 0.001). Our study has shown a very high exposure to SARS-CoV-2 among students which positively suggests a near attainment of herd immunity and negatively unreliability of the current mitigation measures. We recommend such evidence-based results should guide policy directions and decisions in the current and future pandemics.

  • Open Access

    Estrogen promotes innate immune evasion of Candida albicans through inactivation of the alternative complement system

    by Pizga Kumwenda, Fabien Cottier, Alexandra C. Hendry, Davey Kneafsey, Ben Keevan, Hannah Gallagher, Hung-Ji Tsai, Rebecca A. Hall


  • Open Access

    Comparative characterisation of COVID-19 patients with hypertension comorbidity in Malawi: a 1:2 matched retrospective case-control study

    by Master R.O. Chisale, Billy W. Nyambalo, Collins Mitambo, Pizga Kumwenda, Saul E. Mwale, Balwani Chingatichifwe Mbakaya


  • Open Access

    Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis

    by Master R. O. Chisale, Sheena Ramazanu, Saul Eric Mwale, Pizga Kumwenda, Mep Chipeta, Atipatsa C. Kaminga, Obed Nkhata, Billy Nyambalo, Elton Chavura, Balwani C. Mbakaya

    We estimated the seroprevalence of anti‐severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antibodies in residents of African countries and explored its associated factors. We searched PubMed, EMBASE, PsycINFO, AMED, CINAHL, DOAJ and Google Scholar databases for peer reviewed articles and pre‐prints that reported anti‐SARS‐CoV‐2 antibody seroprevalence of general or specific human populations resident in Africa. The eligible studies were evaluated using Joana Briggs Institute prevalence critical appraisal tool. Twenty‐three studies involving 27,735 individuals were included in our paper. The pooled seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa was 22% (95%CI: 14–31) with very high heterogeneity (I2 = 100%, p < 0.001). Seroprevalence was highest in studies conducted in Central Africa compared to Southern Africa, West Africa, North Africa and East Africa respectively. The number of days between the first reported coronavirus disease 2019 case in each country and when a seroprevalence study was conducted was a significant moderator of seroprevalence. Seropositivity was numerically influenced by gender and age of the participants with males and those aged below 50 years being most affected with SARS‐CoV‐2 infection. The highest pooled seroprevalence in Africa reported in this review should be interpreted cautiously due to high heterogeneity between studies. Continued seroprevalence surveillance is warranted to establish Africa's transition towards herd immunity.